Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Path To Alternative Methods: Labeling Guidelines, “3Rs” Plan Issued

This article was originally published in The Rose Sheet

Executive Summary

Cosmetics manufacturers using alternative testing methods may label their products with a statement indicating "no animal tests have been carried out" under guidelines published June 7 by the European Commission

You may also be interested in...



European Commissioner Gives Update On Movement To Replace Animal Tests

Freer communication and a stronger spirit of solidarity among European stakeholders, in addition to the continued participation of colleagues in the U.S. and Japan, are critical to advancing the development of non-animal test strategies, according to European Commissioner for Science and Research Janez Poto?nik

European Commissioner Gives Update On Movement To Replace Animal Tests

Freer communication and a stronger spirit of solidarity among European stakeholders, in addition to the continued participation of colleagues in the U.S. and Japan, are critical to advancing the development of non-animal test strategies, according to European Commissioner for Science and Research Janez Poto?nik

SACATM Examines Federal Five-Year Plan For Non-Animal Toxicity Research

The Scientific Advisory Committee on Alternative Toxicological Methods considered a proposed federal research priority ranking for the development of non-animal-based approaches to toxicity testing at a Nov. 30 meeting in Research Triangle Park, N.C

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014029

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel